
### [MONDO:0019460](http://purl.obolibrary.org/obo/MONDO_0019460)
**Label:** acute leukemia of ambiguous lineage

**Subclasses:** [MONDO:0020526](http://purl.obolibrary.org/obo/MONDO_0020526) (acute megakaryoblastic leukemia in down syndrome), [MONDO:0019458](http://purl.obolibrary.org/obo/MONDO_0019458) (acute basophilic leukemia), [MONDO:0017893](http://purl.obolibrary.org/obo/MONDO_0017893) (inherited acute myeloid leukemia), [MONDO:0019456](http://purl.obolibrary.org/obo/MONDO_0019456) (acute myeloid leukemia with multilineage dysplasia), [MONDO:0018004](http://purl.obolibrary.org/obo/MONDO_0018004) (acute megakaryoblastic leukemia without down syndrome), [MONDO:0012883](http://purl.obolibrary.org/obo/MONDO_0012883) (acute promyelocytic leukemia), [MONDO:0018871](http://purl.obolibrary.org/obo/MONDO_0018871) (acute myelomonocytic leukemia M4), [MONDO:0017894](http://purl.obolibrary.org/obo/MONDO_0017894) (acute myeloid leukemia with CEBPA somatic mutations), [MONDO:0018872](http://purl.obolibrary.org/obo/MONDO_0018872) (acute megakaryoblastic leukemia), [MONDO:0020320](http://purl.obolibrary.org/obo/MONDO_0020320) (acute myeloblastic leukemia with maturation), [MONDO:0020321](http://purl.obolibrary.org/obo/MONDO_0020321) (acute undifferentiated leukemia), [MONDO:0020322](http://purl.obolibrary.org/obo/MONDO_0020322) (acute biphenotypic leukemia), [MONDO:0000875](http://purl.obolibrary.org/obo/MONDO_0000875) (adult acute monocytic leukemia), [MONDO:0004996](http://purl.obolibrary.org/obo/MONDO_0004996) (childhood acute myeloid leukemia), [MONDO:0005224](http://purl.obolibrary.org/obo/MONDO_0005224) (acute myeloblastic leukemia without maturation), [MONDO:0007896](http://purl.obolibrary.org/obo/MONDO_0007896) (acute monocytic leukemia), [MONDO:0005223](http://purl.obolibrary.org/obo/MONDO_0005223) (minimally differentiated acute myeloblastic leukemia), [MONDO:0007573](http://purl.obolibrary.org/obo/MONDO_0007573) (acute erythroleukemia, familial), [MONDO:0004051](http://purl.obolibrary.org/obo/MONDO_0004051) (aleukemic monocytic leukemia cutis), [MONDO:0011118](http://purl.obolibrary.org/obo/MONDO_0011118) (bilineal acute myeloid leukemia), 

**Mapped go classes:** [GO:0014068](http://purl.obolibrary.org/obo/GO_0014068) (positive regulation of phosphatidylinositol 3-kinase signaling), [GO:0008584](http://purl.obolibrary.org/obo/GO_0008584) (male gonad development), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0032689](http://purl.obolibrary.org/obo/GO_0032689) (negative regulation of interferon-gamma production), [GO:0032720](http://purl.obolibrary.org/obo/GO_0032720) (negative regulation of tumor necrosis factor production), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0042826](http://purl.obolibrary.org/obo/GO_0042826) (histone deacetylase binding), [GO:0060591](http://purl.obolibrary.org/obo/GO_0060591) (chondroblast differentiation), [GO:0031076](http://purl.obolibrary.org/obo/GO_0031076) (embryonic camera-type eye development), [GO:0000900](http://purl.obolibrary.org/obo/GO_0000900) (translation repressor activity, nucleic acid binding), [GO:0044323](http://purl.obolibrary.org/obo/GO_0044323) (retinoic acid-responsive element binding), [GO:0005876](http://purl.obolibrary.org/obo/GO_0005876) (spindle microtubule), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0051099](http://purl.obolibrary.org/obo/GO_0051099) (positive regulation of binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0051897](http://purl.obolibrary.org/obo/GO_0051897) (positive regulation of protein kinase B signaling), [GO:0051018](http://purl.obolibrary.org/obo/GO_0051018) (protein kinase A binding), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0045947](http://purl.obolibrary.org/obo/GO_0045947) (negative regulation of translational initiation), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0045787](http://purl.obolibrary.org/obo/GO_0045787) (positive regulation of cell cycle), [GO:0045666](http://purl.obolibrary.org/obo/GO_0045666) (positive regulation of neuron differentiation), [GO:0051393](http://purl.obolibrary.org/obo/GO_0051393) (alpha-actinin binding), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0043401](http://purl.obolibrary.org/obo/GO_0043401) (steroid hormone mediated signaling pathway), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0002068](http://purl.obolibrary.org/obo/GO_0002068) (glandular epithelial cell development), [GO:0003148](http://purl.obolibrary.org/obo/GO_0003148) (outflow tract septum morphogenesis), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0001012](http://purl.obolibrary.org/obo/GO_0001012) (RNA polymerase II regulatory region DNA binding), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0048384](http://purl.obolibrary.org/obo/GO_0048384) (retinoic acid receptor signaling pathway), [GO:0048027](http://purl.obolibrary.org/obo/GO_0048027) (mRNA 5'-UTR binding), [GO:0004879](http://purl.obolibrary.org/obo/GO_0004879) (nuclear receptor activity), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0003707](http://purl.obolibrary.org/obo/GO_0003707) (steroid hormone receptor activity), [GO:0003708](http://purl.obolibrary.org/obo/GO_0003708) (retinoic acid receptor activity), [GO:0035014](http://purl.obolibrary.org/obo/GO_0035014) (phosphatidylinositol 3-kinase regulator activity), [GO:0060010](http://purl.obolibrary.org/obo/GO_0060010) (Sertoli cell fate commitment), [GO:0030917](http://purl.obolibrary.org/obo/GO_0030917) (midbrain-hindbrain boundary development), [GO:0071391](http://purl.obolibrary.org/obo/GO_0071391) (cellular response to estrogen stimulus), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0060534](http://purl.obolibrary.org/obo/GO_0060534) (trachea cartilage development), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0003713](http://purl.obolibrary.org/obo/GO_0003713) (transcription coactivator activity), [GO:0071300](http://purl.obolibrary.org/obo/GO_0071300) (cellular response to retinoic acid), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0001657](http://purl.obolibrary.org/obo/GO_0001657) (ureteric bud development), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding), [GO:0055012](http://purl.obolibrary.org/obo/GO_0055012) (ventricular cardiac muscle cell differentiation), [GO:0043422](http://purl.obolibrary.org/obo/GO_0043422) (protein kinase B binding), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0060324](http://purl.obolibrary.org/obo/GO_0060324) (face development), [GO:0032526](http://purl.obolibrary.org/obo/GO_0032526) (response to retinoic acid), [GO:0048167](http://purl.obolibrary.org/obo/GO_0048167) (regulation of synaptic plasticity), [GO:0015629](http://purl.obolibrary.org/obo/GO_0015629) (actin cytoskeleton), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development), [GO:0017148](http://purl.obolibrary.org/obo/GO_0017148) (negative regulation of translation), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0043277](http://purl.obolibrary.org/obo/GO_0043277) (apoptotic cell clearance), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0003417](http://purl.obolibrary.org/obo/GO_0003417) (growth plate cartilage development), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0030853](http://purl.obolibrary.org/obo/GO_0030853) (negative regulation of granulocyte differentiation), [GO:0032753](http://purl.obolibrary.org/obo/GO_0032753) (positive regulation of interleukin-4 production), [GO:0032754](http://purl.obolibrary.org/obo/GO_0032754) (positive regulation of interleukin-5 production), [GO:0030852](http://purl.obolibrary.org/obo/GO_0030852) (regulation of granulocyte differentiation), [GO:0061037](http://purl.obolibrary.org/obo/GO_0061037) (negative regulation of cartilage development), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0021575](http://purl.obolibrary.org/obo/GO_0021575) (hindbrain morphogenesis), [GO:0060348](http://purl.obolibrary.org/obo/GO_0060348) (bone development), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0045471](http://purl.obolibrary.org/obo/GO_0045471) (response to ethanol), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:0045596](http://purl.obolibrary.org/obo/GO_0045596) (negative regulation of cell differentiation), [GO:0007281](http://purl.obolibrary.org/obo/GO_0007281) (germ cell development), [GO:0031490](http://purl.obolibrary.org/obo/GO_0031490) (chromatin DNA binding), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0060173](http://purl.obolibrary.org/obo/GO_0060173) (limb development), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0045630](http://purl.obolibrary.org/obo/GO_0045630) (positive regulation of T-helper 2 cell differentiation), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0001972](http://purl.obolibrary.org/obo/GO_0001972) (retinoic acid binding), [GO:0032736](http://purl.obolibrary.org/obo/GO_0032736) (positive regulation of interleukin-13 production), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0071222](http://purl.obolibrary.org/obo/GO_0071222) (cellular response to lipopolysaccharide), [GO:0005938](http://purl.obolibrary.org/obo/GO_0005938) (cell cortex), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0005819](http://purl.obolibrary.org/obo/GO_0005819) (spindle), [GO:0031641](http://purl.obolibrary.org/obo/GO_0031641) (regulation of myelination), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), 

**Class expressions from DL-Learner:**

- Thing 53.94%
- [GO:0060534](http://purl.obolibrary.org/obo/GO_0060534) (trachea cartilage development) 51.32%
- [GO:0060351](http://purl.obolibrary.org/obo/GO_0060351) (cartilage development involved in endochondral bone morphogenesis) 51.32%
- [GO:0060324](http://purl.obolibrary.org/obo/GO_0060324) (face development) 51.32%
- [GO:0060173](http://purl.obolibrary.org/obo/GO_0060173) (limb development) 51.32%
- [GO:0060010](http://purl.obolibrary.org/obo/GO_0060010) (Sertoli cell fate commitment) 51.32%
- [GO:0048232](http://purl.obolibrary.org/obo/GO_0048232) (male gamete generation) 51.32%
- [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth) 51.32%
- [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development) 51.32%
- [GO:0031076](http://purl.obolibrary.org/obo/GO_0031076) (embryonic camera-type eye development) 51.32%
- [GO:0030917](http://purl.obolibrary.org/obo/GO_0030917) (midbrain-hindbrain boundary development) 51.32%
- [GO:0008584](http://purl.obolibrary.org/obo/GO_0008584) (male gonad development) 51.32%
- [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis) 51.32%
- [GO:0003417](http://purl.obolibrary.org/obo/GO_0003417) (growth plate cartilage development) 51.32%
- [GO:0001657](http://purl.obolibrary.org/obo/GO_0001657) (ureteric bud development) 51.32%


